Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses.
Fatigued patients with multiple sclerosis can be discriminated from healthy controls by the recordings of a newly developed measurement system (FAMOS): a pilot study.
How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?-Reply.
[Therapeutic effect of encapsulated into the nanocontainers MBP immunodominant peptides on EAE development in DA rats].
New Microparticle Secondary Progressive MS Therapy Dosing Tested In Australian Clinical Trial
How can we exploit the brain's ability to repair itself?
Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.
Design and analysis of three-arm trials with negative binomially distributed endpoints.
JC virus Reactivation During Prolonged Natalizumab Monotherapy for Multiple Sclerosis.
Minocycline-induced attenuation of iron overload and brain injury after experimental intracerebral hemorrhage.
Interferon-β1b Increases Th2 Response in Neuromyelitis Optica.
Ready or not: planning for health declines in couples with advanced multiple sclerosis.
Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States.
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.
The Impact of a Patient Support Program for Multiple Sclerosis on Patient Satisfaction and Subjective Health Status.
Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.
Reported outcomes after the endovascular treatment of chronic cerebrospinal venous insufficiency.
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
Expert recommendations to personalization of medical approaches in treatment of Multiple Sclerosis: an overview of family planning and pregnancy.
Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
Developing a therapeutic plan for treating MS: evidence for new treatments.
Diverse functional roles of lipocalin-2 in the central nervous system.
Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders.
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study.
Relationship Between Cerebrospinal Fluid Protein Levels and Electrophysiologic Abnormalities in Guillain-Barré Syndrome.
Pages
« first
‹ previous
…
263
264
265
266
267
268
269
270
271
…
next ›
last »